HEXO Stock: When Will the Pain End?

After another new 52-week low, HEXO (HEXO) has become a perplexing stock that should benefit from some of the chaos in the Canadian cannabis sector that...

Aurora Cannabis (ACB): Partnerships Are a Critical Part of the Future

It remains extraordinary to me that many commentators, analysts and pundits continue to be in denial concerning the partnership strategy of Aurora Cannabis...

Aphria (APHA): CIBC Sees Choppier Waters Ahead for the Cannabis Stock

With less than a week to go before Q4 earnings come out, eyes are beginning to turn to Canadian medical marijuana stock Aphria (APHA) -- in a bad way. On...

CannTrust (CTST) CEO Is Out, and the Stock Is Soaring

Historically, Wall Street frowns at unpredictable executive turnover. Its exuberant reaction to CannTrust's (CTST) abrupt change of chief executive is a...

Why the Dip in Cannabis Stock Curaleaf Shouldn’t Spook You

The cannabis sector remains the wild, wild west and Curaleaf Holdings (CURLF) provided a prime example over the last week. The company was turning into a beast...

Aurora Cannabis (ACB) and UFC Enter into Collaboration to Conduct Research on Use of Hemp-Derived CBD Products by MMA Athletes

Aurora Cannabis (ACB) announced the launch of a joint clinical research program that will produce multiple studies under the terms of their recently announced...

Canopy Growth (CGC) Getting Knocked Down a Peg is Good for the Company and Sector

Canopy Growth (CGC) has been taking a beating lately, as it has taken it on the nose after its disappointing earnings report and co-CEO Bruce Linton getting...

Short-Term Outlook for Neptune Wellness Solutions (NEPT) Looks Challenging

Neptune Wellness Solutions (NEPT) has been on a tear lately, soaring nearly 40% since July 9 to trade at $6.14 per share as I write. Taking into account the...

Aphria (APHA) Stock Moves Beyond Turbulence

Over the last few months, Aphria (APHA) has generally disappeared from the headlines. Last year, the Canadian cannabis player faced a short seller attack...

Curaleaf Holdings: FDA Warning Letter Creates Buying Opportunity, Says Analyst

If you own shares of Curaleaf (CURLF) stock, we have good news and bad news for you. The good news: As of 2:55 p.m. EDT, Curaleaf stock is down "only" 5%. The...

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts